Cannot sell in Utah in a general market as the state bans using a cannabinoid as a food additive except :(i) a gummy if the gummy is shaped as a gelatinous cube or gelatinous rectangular cuboid or in another basic geometric shape and not in a shape that could be considered appealing to children such as a star shape, fruit, or animal shape; or (ii) a liquid suspension under two ounces.

Anyone selling a cannabinoid product must obtain an industrial hemp retailer permit first. But see the definition of allowable dosages.

Y, annual registration. Information required includes: (a) the name and address of the applicant and the name and address of the person whose name will appear on the label, if other than the applicants;(b) the name of the product;(c) the type and use of the product;(d) a complete copy of the label as it will appear on the product in a legible format; and (e) if the product has been assigned a National Drug Code in accordance with 21 CFR 207.33, the applicant shall provide the National Drug Code number. The application will also need to include the COA. Utah Admin Code R66-35-3.

See Utah Admin Code R66-34-4. A new registration is required for any of the following:(a) any change in the cannabinoid product ingredients;(b) any change to the directions for use; and(c) any change of name for the product.(7) Other changes may not require a new registration but the registrant shall submit copies of each label change to the department as soon as they are effective. Utah Admin Code R66-35-3.

See Utah Admin Code R66-35-5:

(1) The label of a cannabinoid product shall contain the following information, legibly displayed:(a) product name or common name, on the front of the label;(b) brand name, on the front of the label;(c) the size of the container or net count of individual items, on the front of the label;(d) net weight;(e) the suggested use of the product, including serving size if the product is intended for consumption;(f) list of ingredients, including:(i) the amount of any advertised cannabinoid listed as present on the COA;(ii) the amount of any primary cannabinoid listed as present on the COA; and(iii) the amount of any THC or any THC analog listed as present on the COA;(g) list of allergens;(h) manufacturer, packer, or distributor name and address; and (i) batch number. A fact panel may be included on the product label if it is not identified as a Drug Fact Panel or Nutritional Fact Panel.

A cannabinoid product shall have on the label a scannable barcode, QR code, or web address with an easily located certificate of analysis for the batch identified, containing the information required in Section R66-35-4. Cannabinoid products may not contain medical claims on the label unless the product has been registered with the FDA and is labeled in accordance with Subsection R66-35-5(5). Cannabinoid product labeling shall clearly show that the product contains material derived from industrial hemp and not cannabis or medical cannabis. Cannabinoid product labeling may not:(a) have any likeness bearing resemblance to a cartoon character or fictional character; or(b) appear to imitate a food or other product that is typically marketed toward or appealing to children.

WARNING STATEMENT: The label of each product intended for human consumption or intended to be vaporized for inhalation shall include the following text, prominently displayed: "This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." Cannabinoid products containing a cannabinoid other than CBD produced for absorption by humans shall contain the following text, prominently displayed: "Warning - The safety of this product has not been determined."